Search details
1.
SLFN11 Blocks Stressed Replication Forks Independently of ATR.
Mol Cell
; 69(3): 371-384.e6, 2018 02 01.
Article
in English
| MEDLINE | ID: mdl-29395061
2.
Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein Targets.
Mol Cell Proteomics
; 22(8): 100602, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37343696
3.
CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.
Nucleic Acids Res
; 49(D1): D1083-D1093, 2021 01 08.
Article
in English
| MEDLINE | ID: mdl-33196823
4.
rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R.
Bioinformatics
; 32(8): 1272-4, 2016 04 15.
Article
in English
| MEDLINE | ID: mdl-26635141
5.
Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer.
Hum Genet
; 134(1): 3-11, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25213708
6.
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Cancer Discov
; 13(4): 928-949, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36715552
7.
Replication stress defines distinct molecular subtypes across cancers.
Cancer Res Commun
; 2(6): 503-517, 2022 06.
Article
in English
| MEDLINE | ID: mdl-36381660
8.
RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis.
BMC Bioinformatics
; 12: 52, 2011 Feb 10.
Article
in English
| MEDLINE | ID: mdl-21310028
9.
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents.
Mol Cancer Ther
; 20(8): 1431-1441, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34045232
10.
Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq.
Virchows Arch
; 478(3): 569-579, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-32474729
11.
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.
Sci Transl Med
; 13(578)2021 01 27.
Article
in English
| MEDLINE | ID: mdl-33504652
12.
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.
Cancer Cell
; 39(4): 566-579.e7, 2021 04 12.
Article
in English
| MEDLINE | ID: mdl-33848478
13.
Phenotype stability under dynamic brain-tumor environment stimuli maps glioblastoma progression in patients.
Sci Adv
; 6(22): eaaz4125, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32832595
14.
Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair-deficient tumors.
Cold Spring Harb Mol Case Stud
; 6(5)2020 10.
Article
in English
| MEDLINE | ID: mdl-33028646
15.
SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures.
Cell Rep
; 33(3): 108296, 2020 10 20.
Article
in English
| MEDLINE | ID: mdl-33086069
16.
Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors.
Front Oncol
; 9: 994, 2019.
Article
in English
| MEDLINE | ID: mdl-31632920
17.
Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines.
iScience
; 21: 664-680, 2019 Nov 22.
Article
in English
| MEDLINE | ID: mdl-31733513
18.
Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (SLFN11) Expression with Class I Histone Deacetylase Inhibitors.
Clin Cancer Res
; 24(8): 1944-1953, 2018 04 15.
Article
in English
| MEDLINE | ID: mdl-29391350
19.
CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines.
iScience
; 10: 247-264, 2018 Dec 21.
Article
in English
| MEDLINE | ID: mdl-30553813
20.
Temozolomide in the Era of Precision Medicine.
Cancer Res
; 77(4): 823-826, 2017 02 15.
Article
in English
| MEDLINE | ID: mdl-28159862